Serveur d'exploration Tocilizumab - Analysis (2020)

Index « Titre (en) » - entrée « against »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
after < against < age  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000049 (2020) Yeimer Ortiz-Martínez [Colombie]Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.
000199 (2020) Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis]Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
000223 (2020) Chih-Chia Lu [République populaire de Chine] ; Mei-Yu Chen [République populaire de Chine] ; Yuh-Lih ChangPotential therapeutic agents against COVID-19: What we know so far
000321 (2020) Biswaranjan Paital [Inde] ; Kabita Das [Inde] ; Sarat Kumar Parida [Inde]Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India
000373 (2020) Hongzhuan Xuan [République populaire de Chine] ; Aiqun Ou ; Shengyu Hao ; Jiajun Shi ; Xiaolu Jin [République populaire de Chine]Galangin Protects against Symptoms of Dextran Sodium Sulfate-Induced Acute Colitis by Activating Autophagy and Modulating the Gut Microbiota
000383 (2020) Hai-Jian Tu [République populaire de Chine] ; Cheng-Fei Zhao [République populaire de Chine] ; Zhi-Wei Chen [République populaire de Chine] ; Wei Lin [République populaire de Chine] ; Yu-Cai Jiang [République populaire de Chine]Fibroblast Growth Factor (FGF) Signaling Protects Against Acute Pancreatitis-Induced Damage by Modulating Inflammatory Responses
000451 (2020) Yue Zhang ; Qianhao Xu ; Zhuoyan Sun ; Lei ZhouCurrent targeted therapeutics against COVID-19: based on first-line experience in china
000524 (2020) Dwight L. Mckee [États-Unis] ; Ariane Sternberg [Allemagne] ; Ulrike Stange [Allemagne] ; Stefan Laufer [Allemagne] ; Cord Naujokat [Allemagne]Candidate drugs against SARS-CoV-2 and COVID-19
000573 (2020) Izabela Szczygielska ; El Bieta Hernik ; Agnieszka Gazda ; Beata Kołodziejczyk ; Piotr GietkaAssessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "against" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "against" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    against
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021